Glucotrack's registered direct offering and immediately exercisable pre-funded warrants will increase shares outstanding and dilute current owners. Proceeds of about $3.1M will pay debt and help operations.
The deal sells 169,388 shares plus pre-funded warrants to buy 1,350,220 shares, exercisable immediately, so share count can jump and dilute owners. The cash raised will pay debt but does not avoid dilution.
Follow Glucotrack, Inc. (GCTK) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GCTK